Discontinued — last reported Q3 '23
Biogen Total investment securities increased by 16.3% to $137.40M in Q1 2026 compared to the prior quarter.
Growth often reflects the deployment of excess liquidity into interest-earning assets, while a decline may signal liquidity needs or portfolio rebalancing.
This metric is the sum of Available-for-Sale (AFS) and Held-to-Maturity (HTM) investment securities held by the bank. It...
Universal metric for all commercial and investment banks.
fin_total_investment_securities| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $118.10M | $137.40M |
| QoQ Change | — | +16.3% |